Journal of Hepatology and Gastrointestinal disorders
Open Access
ISSN: 2475-3181
ISSN: 2475-3181
Edna Aurelus
Wagner College, USA
Posters & Accepted Abstracts: J Hepatol Gastroint Dis
Statement of the Problem: Overweight and obesity are significant problems in patients being treated with anti-psychotic medications. Obesity has reached epidemic proportions in the United States, affecting over 72 million adults. Obesity related conditions or metabolic syndrome include cardiovascular diseases, diabetes and certain types of cancer are some of the leading cause of preventable death. Aim: The aim of this project was to implement an evidence-based educational program in a behavioral health setting with an overall goal of decreasing weight gain in patients who are prescribed antipsychotic medicines. Design used was quasiexperimental. Method: A 12 week-long program was designed for people who are prescribed a regimen of anti-psychotic medicines. The program included guidelines for regular exercise and diet, along with a weekly 1-hour session of dietary and exercise education. There were seven participants at the beginning of the program. Five completed the program. A pre- and postprogram questionnaire was administered to assess attitudes and behaviors about eating. Findings: Participants experienced statistically significant weight reduction (P=0.043). There were no statistical differences on the participants�?? waist circumference and BMI. Inconsistent attendance may have negatively impacted the results. However, the results were effective in showing no weight gain among all participants. Conclusion: An educational program to help prevent weight gain induced by anti-psychotic medication can be impactful to the health care system.
E-mail: edna.aurelus@gmail.com